The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Laura J. V. Piddock

Antimicrobial Agents Research Group

School of Immunity and Infection

College of Medical and Dental Sciences

University of Birmingham

UK

[email]@bham.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Antimicrobial Agents Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, UK. 1997 - 2010
  • Department of Infection, University of Birmingham, UK. 1996 - 1999

References

  1. Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. Piddock, L.J., Garvey, M.I., Rahman, M.M., Gibbons, S. J. Antimicrob. Chemother. (2010) [Pubmed]
  2. Persistence of Campylobacter species, strain types, antibiotic resistance and mechanisms of tetracycline resistance in poultry flocks treated with chlortetracycline. Piddock, L.J., Griggs, D., Johnson, M.M., Ricci, V., Elviss, N.C., Williams, L.K., Jørgensen, F., Chisholm, S.A., Lawson, A.J., Swift, C., Humphrey, T.J., Owen, R.J. J. Antimicrob. Chemother. (2008) [Pubmed]
  3. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Piddock, L.J. Clin. Microbiol. Rev. (2006) [Pubmed]
  4. Multidrug-resistance efflux pumps - not just for resistance. Piddock, L.J. Nat. Rev. Microbiol. (2006) [Pubmed]
  5. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. Piddock, L.J., Ricci, V., Pumbwe, L., Everett, M.J., Griggs, D.J. J. Antimicrob. Chemother. (2003) [Pubmed]
  6. Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria. Piddock, L.J., Johnson, M.M., Webber, M.A. J. Antimicrob. Chemother. (2003) [Pubmed]
  7. Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae. Piddock, L.J., Johnson, M.M., Simjee, S., Pumbwe, L. Antimicrob. Agents Chemother. (2002) [Pubmed]
  8. Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae. Piddock, L.J., Johnson, M.M. Antimicrob. Agents Chemother. (2002) [Pubmed]
  9. Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus. Piddock, L.J., Jin, Y.F., Webber, M.A., Everett, M.J. Antimicrob. Agents Chemother. (2002) [Pubmed]
  10. Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv. Piddock, L.J., Ricci, V. J. Antimicrob. Chemother. (2001) [Pubmed]
  11. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis. Piddock, L.J., Williams, K.J., Ricci, V. J. Antimicrob. Chemother. (2000) [Pubmed]
  12. Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis. Piddock, L.J., Ricci, V. J. Antimicrob. Chemother. (2000) [Pubmed]
  13. Activity of antibiotics used in human medicine for Campylobacter jejuni isolated from farm animals and their environment in Lancashire, UK. Piddock, L.J., Ricci, V., Stanley, K., Jones, K. J. Antimicrob. Chemother. (2000) [Pubmed]
  14. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Piddock, L.J., White, D.G., Gensberg, K., Pumbwe, L., Griggs, D.J. Antimicrob. Agents Chemother. (2000) [Pubmed]
  15. Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli. Piddock, L.J., Jin, Y.F., Ricci, V., Asuquo, A.E. J. Antimicrob. Chemother. (1999) [Pubmed]
  16. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Piddock, L.J. Drugs (1999) [Pubmed]
  17. Antibacterials - mechanisms of action. Piddock, L.J. Curr. Opin. Microbiol. (1998) [Pubmed]
  18. Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom. Piddock, L.J., Ricci, V., McLaren, I., Griggs, D.J. J. Antimicrob. Chemother. (1998) [Pubmed]
  19. Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Piddock, L.J., Johnson, M., Ricci, V., Hill, S.L. Antimicrob. Agents Chemother. (1998) [Pubmed]
  20. Prevalence and mechanism of resistance to 'third-generation' cephalosporins in clinically relevant isolates of Enterobacteriaceae from 43 hospitals in the UK, 1990-1991. Piddock, L.J., Walters, R.N., Jin, Y.F., Turner, H.L., Gascoyne-Binzi, D.M., Hawkey, P.M. J. Antimicrob. Chemother. (1997) [Pubmed]
  21. Non-gyrA-mediated ciprofloxacin resistance in laboratory mutants of Streptococcus pneumoniae. Piddock, L.J., Jin, Y.F., Everett, M.J. J. Antimicrob. Chemother. (1997) [Pubmed]
  22. Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy?. Piddock, L.J. J. Antimicrob. Chemother. (1996) [Pubmed]
 
WikiGenes - Universities